维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Cheli CD"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Evaluation of the clinical performance of equimolar- and skewed-response total prostate-specific antigen assays versus complexed and free PSA assays and their ratios indiscriminating between benign prostatic hyperplasia and prostate cancer显示文摘	Wians FH Jr Cheli CD Balko JA	2002	Clin Chim Acta2002，326，12：	1
2	Complexed proatate-specificantigen as a staging tool results based on a multicenterprospective evaluation of complexed prostate-specific antigen incancer diagnosis显示文摘	Taneja SS Hsu EI Cheli CD	2002	Urology2002，60，4：	1
3	Prostate specific antigen isoforms and human glandular kallikrein 2-which offers the best screening performance in a predominantly black population?显示文摘	Martin B J Cheli CD Sterling K	2006	J Urol2006，175，1：	1
4	Volume indexes of total,free, and complexed prostate-speciflc antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer 显示文摘	Naya Y Fritsche HA Cheli CD	2003	Urology2003，62，6：	1
5	Comparative analysis of complexed prostate specific antigen,free prostate specific antigen and their ratio in detecting prostate cancer显示文摘	Okihara K Cheli CD Partin AW	2002	J Urol2002，167，5：	1
6	Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter显示文摘	Horninger W Cheli CD Babaian RJ	2002	Urology2002，60，4：	1
7	Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies显示文摘	Esteva FJ Cheli CD Fritsche H	2005	Breast Cancer Res2005，7，4：	1
8	Clinical utility of serum HER2/neu in monitoring and prediction of progression-free sur- vival in metastatic breast cancer patients treated with trastuzumab- based therapies 显示文摘	Esteva FJ Cheli CD Fritsche H	2005	Breast Cancer Res2005，7，4：	1
9	Can volume measurement of the prostate enhance the performance of complexed prostate - specific an- tigen显示文摘	Naya Y Stamey TA Cheli CD	2002	Urology2002，60，4：	1
10	Volume indexes of total, free, and complexed prostate - specific antigen enhance prediction of extra- prostatic disease extension in men with nonpalpable prostate cancer 显示文摘	Naya Y Fritsche HA Cheli CD	2003	Urology2003，62，6：	1
11	Can volume measurement of the Prostate enhance the performance of complex Prostate-specific an- tigen显示文摘	Naya Y Stamey A Cheli CD	2002	Urology2002，60，41：	1
12	Clinical utility of serumHER2/neu in monitoring and prediction of progression-free survivalin metastatic breast cancer patients treated with trastuzumab-basedtherapies显示文摘	Esteva FJ Cheli CD Fritsche H	2005	Breast Cancer Res2005，7，4：	1
13	Complexed prostate-specific antigen as a staging tool: results based on a muhicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis显示文摘	TANEJA SS HSU EI CHELI CD	2002	Urology2002，60，4：	1
14	Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumabbased therapies 显示文摘	Esteva FJ Cheli CD Fritsche H	2005	Breast Cancer Res2005，7，4：	1
15	Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer显示文摘	Brawer MK Cheli CD Neaman IE	2000	J Urol2000，163，：	1
16	Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer显示文摘	NAYA Y FRITSCHE HA CHELI CD	2003	Urology2003，62，6：	1
17	Comparative analysis of complexed prostate specific antigen,free prostate specific antigen, and their ratio in detecting prostate cancer显示文摘	Okihara K Cheli CD Partin AW	2002	J Urol2002，167，5：	1
18	Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies显示文摘	Esteva FJ Cheli CD Fritsche H	2005	Breast Cancer Res2005，7，：	1
19	Clinical utility of serum HER2/neu in monitoring and prediction of pro- gression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies 显示文摘	Esteva FJ Cheli CD Fritsche H	2005	Breast Cancer Res2005，7，4：	1
20	Complexed prostate- specific antigen as a staging tool: results based on a multi- center prospective evaluation of prostate-specific antigen in cancer diagnosis显示文摘	Tanega SS Hsu EI Cheli CD	2002	Urology2002，60，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示